BioSign® Flu A + B
1 /1Page

BioSign® Flu A + B

BioSign® Flu A + B
1 /1Page

Catalog excerpts

BioSign® Flu A + B-1

An in vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens* SIMPLE PROCEDURE1 FOR SWAB SPECIMENS Differentiates between Influenza A and B EXTRACT Fill extraction well with reagent. INCUBATE Insert collection swab and incubate for 1 minute. FLIP Tip device for 1-2 seconds allowing liquid to flow. READ RESULTS IN 10 TO 15 MINUTES. POSITIVE AND NEGATIVE CONTROL SWABS READING RESULTS 1 VALID TEST RESULTS NEGATIVE INNOVATIVE FLIP DESIGN WITH ONBOARD SAMPLE EXTRACTION PRE-MEASURED DEVELOPER SOLUTION CAPSULE for increased accuracy and ease of use FLOCKED NASAL SWABS for improved patient comfort and superior specimen collection INVALID TEST RESULTS A LINE: Influenza type A B LINE: Influenza type B A & B LINE: Influenza type A & B Repeat with new sample and device. PROVEN CLINICAL PERFORMANCE (BioSign® Flu A & B vs, PCR) POSITIVE % AGREEMENT NEGATIVE % AGREEMENT THE TESTS YOU WANT. THE ACCURACY YOU NEED! ©2019 Germaine Laboratories, Inc., CSM 0800-31 , Rev. 01-19 * CPT reimbursements vary, check your state for current amounts 1 See Package Insert for complete details. Check with each state for exact reimbursement. • Nasal Aspirate Specim

 Open the catalog to page 1

All Germaine Laboratories catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.